文献速递系统性红斑狼疮血管炎

血小板补体沉积C4d与系统性红斑狼疮血管事件相关

Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该横断面研究纳入308例系统性红斑狼疮(SLE)患者和308例匹配的普通人群对照,用流式细胞术检测血小板C4d(PC4d)沉积。SLE患者PC4d阳性率显著高于对照(50% vs 5%,P<0.0001),PC4d阳性与任何血管事件、静脉事件、脑血管事件及所有抗磷脂抗体(aPL)谱相关;校正传统及SLE相关危险因素后,PC4d阳性与任何血管事件的关联仍有统计学意义(OR 2.3,95%CI 1.3-4.3,P=0.008)。PC4d与狼疮抗凝物(LA)双阳性者血管病风险显著增高(OR 12.3,95%CI 5.4-29.3),交互作用归因比0.8(95%CI 0.4-1.1)。

要点

  • SLE患者血小板C4d阳性率50%,显著高于对照的5%(P<0.0001)。
  • 校正传统及SLE相关危险因素后,PC4d阳性与任何血管事件独立相关(OR 2.3,95%CI 1.3-4.3,P=0.008)。
  • PC4d与LA双阳性者血管病风险显著增高(OR 12.3,95%CI 5.4-29.3)。

核心结论

  • PC4d阳性与SLE血管事件独立相关,不受传统及SLE相关危险因素影响。
  • PC4d与LA同时阳性可能交互作用,进一步增加血管事件风险。

研究设计与样本

  • 横断面研究,纳入308例特征明确的SLE患者和308例匹配的普通人群对照。
  • 用流式细胞术分析PC4d沉积,超过对照95%的值定义为PC4d阳性。
  • aPL用Luminex检测,LA用DRVVT试验检测,血管病史在入组时定义。

主要发现

  • SLE患者PC4d沉积较人群对照增加(50% vs 5%,P<0.0001)。
  • PC4d阳性与任何血管事件、静脉事件、脑血管事件及所有检测的aPL谱正相关。
  • 校正传统及SLE相关危险因素后,PC4d阳性与任何血管事件的关联仍有统计学意义(OR 2.3,95%CI 1.3-4.3,P=0.008)。
  • PC4d与LA双阳性者较两者均阴性者血管病风险更高(OR 12.3,95%CI 5.4-29.3;交互作用归因比0.8,95%CI 0.4-1.1)。

关键数值与推荐

  • PC4d阳性定义为超过对照95%的值。
  • PC4d阳性与任何血管事件的校正OR为2.3(95%CI 1.3-4.3,P=0.008)。
  • PC4d与LA双阳性与血管病的OR为12.3(95%CI 5.4-29.3),交互作用归因比0.8(95%CI 0.4-1.1)。

临床怎么用

  • 对SLE患者可考虑检测血小板C4d以辅助评估血管事件风险。
  • PC4d与LA双阳性提示血管事件风险显著增高,需加强监测。
  • 目前证据来自横断面研究,尚不能用于预测血管事件的常规临床决策。

局限性

  • 横断面设计不能确定因果关系或预测价值。
  • PC4d阳性阈值基于对照95%分位,需外部验证。
  • 研究纳入特征明确的SLE患者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Complement components, including C4d, can be found on activated platelets, a process associated with vascular disease in SLE. We investigated whether platelet C4d (PC4d) adds additional value to traditional and known lupus-associated risk factors when identifying SLE patients with vascular disease. METHODS: This cross-sectional study included 308 well-characterized SLE patients and 308 matched general population controls. PC4d deposition was analysed using flow cytometry. Values >95% of controls were considered as PC4d positive (+). aPL were determined by Luminex, and the LA test was performed by DRVVT. History of vascular disease (composite and as separate outcomes) was defined at inclusion. RESULTS: SLE patients had increased PC4d deposition as compared with population controls (50 vs 5%, P < 0.0001). PC4d+ positively associated with any vascular events, and separately with venous and cerebrovascular events, and also with all investigated aPL profiles. The association for any vascular event remained statistically significant after adjustment for traditional and SLE-associated risk factors (odds ratio: 2.3, 95% CI: 1.3, 4.3, P = 0.008). Compared with patients negative for both PC4d and LA, patients with double positivity were more likely to have vascular disease (odds ratio: 12.3, 95% CI: 5.4, 29.3; attributable proportion due to interaction 0.8, 95% CI: 0.4, 1.1). CONCLUSION: PC4d+ is associated with vascular events in SLE, independently of traditional and SLE-associated risk factors. Concurrent presence of PC4d and LA seem to interact to further increase the odds for vascular events. Prospective studies should examine whether the aPL/PC4d combination can improve prediction of vascular events in SLE and/or APS.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Svenungsson E, Gustafsson JT, Grosso G, et al. Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus. Rheumatology (Oxford). 2020. PMID: 32259250. doi:10.1093/rheumatology/keaa092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。